Association of miR-200a and miR-205 Expression with Epithelial-Mesenchymal Transition in Colorectal Cancer Cells
Archives of Advances in Biosciences,
Vol. 11 No. 3 (2020),
26 September 2020
,
Page 13-20
https://doi.org/10.22037/aab.v11i3.31476
Abstract
Abstract
Introduction: MicroRNAs play a critical role in EMT regulation through tightly regulating the transcription factors. EMT (Epithelial-Mesenchymal Transition) in the colorectal cancer cell (CRC) is a highly controlled mechanism, contributing to the development of progressive cancer. Throughout this research, miR-200a/205 was focused as a component implicated throughout regulating the EMT process in colorectal cancer cells. In this sense, the induction of the EMT process was made using colorectal cancer cell lines.
Materials and Methods: The mRNA levels of E-cadherin, Vimentin, β-catenin, Zeb1, and Snail were determined using real time-PCR for characterization of the EMT process. True real time-PCR was conducted for evaluating the alteration amount of microRNAs.
Results: The findings of this study verified the in-vitro EMT model being developed. The in vitro analysis revealed a negative correlation between the Zeb1 and Snail miR-200a and miR205 (P=0.001) (P=0.0001). The results of miR-200a and miR205 are regulated down in vitro.
Conclusion: miR-200a and miR205 may be used as candidates in further research to prevent colorectal cancer's invasive properties via the EMT process.
- Cancer Stem Cells, Colorectal Cancer, miRNAs, EMT, Transcription Factors
How to Cite
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for36cancers in 185 countries,. CA Cancer J Clin. 2018;68 394-424.
Hui C, Enping X, Hong L, Ledong W, Maode L. Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review. Pathology – Research and Practice. 2015;211 557–69.
Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2013.
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre AMJ. Bouvier, Epidemiology and management of liver metastases from colorectal cancer, Ann. Surg. 2006;244:254–9.
Trung V, Pran u, Datta K. Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. . Cancers. 2017.
Murat K, Onder Y, Onder O, Ozgur IC, Esra B, Ibrahim B, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene 2015;567 81–6.
Richard C, Bates. Colorectal Cancer Progression: Integrin alphavbeta6 and the Epithelial-Mesenchymal Transition (EMT).
Keun H, Yuji T, Masanobu T, Francesc B, Takeshi N, Junichi K, et al. MicroRNA-200c modulates epithelial-tomesenchymal transition (EMT) in human colorectal cancer metastasis. Colon 26 June. 2012.
Fidler J. IThe pathogenesis of cancer metastasis: the ‘seed and soil’hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymaltransitions in development and disease. Cell 2009;139 871–90.
Tsai JH, Yang J. Epithelial to mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192–200.
Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005;132:3151–61.
Pálmer HG, Larriba MJ, García JM, Ordóñez-Morán P, Peña C, Peiró S, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;10:917–9.
Pena C, Garcia JM, Silva J, Garcia V, Rodriguez R, Alonso I, et al. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in coloncancer: clinicopathological correlations, Hum. Mol Genet. 2005;14 3361–70.
He X, Chen Z, Jia M, Zhao X, Hay ED. Downregulated E-cadherin expressionindicates worse prognosis in Asian patients with colorectal cancer: evidencefrom meta-analysis, PLOS ONE 8: e70858. An overview of epithelio-mesenchymal. 2013(13).
Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A, et al. Increased expression of Slug and Vimentin as novel predictive biomarkersfor lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis. 2013;34 2548–57.
Roberts AB, Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 2003;100:8621–3.
Park S, Gaur A, Lengyel E, et al. The miR‐200 family determines the epithelial phenotype of cancer cells by targeting the E‐cadherin repressors ZEB1 and ZEB2. Genes Dev, . 2008;22:894–907.
Tania. D, Rut. T, Isabel. M, Gerardo. F, Anna. C, Rosa. A, et al. Role of miR-200 Family Members in Survival of Colorectal Cancer Patients Treated with Fluoropyrimidines. Journal of Surgical Oncology 2014;109:676–83.
Korpal M, Ell B, Buffa F, et al. Direct targeting of Sec23a bmiR‐200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 2011;17:1101–8.
Hurteau G, Carlson J, Roos E, al. e. Stable expression of miR‐ 200c alone is sufficient to regulate TCF8 (ZEB1) and restore Ecadherin expression. Cell Cycle. 2009;8:2064–9.
Gravgaard K, Lyng M, Laenkholm A, et al. The miRNA‐200 family and miRNA‐9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat. 2012;134:207–17.
Barron N, Keenan J, Gammell P, et al. Biochemical relapse following radical prostatectomy and miR‐200a levels in prostate cancer. Prostate 2012;72:1193–9.
Lee J, Park Y, Choi J, et al. The expression of the miRNA‐200. family in endometrial endometrioid carcinoma. Gynecol Oncol. 2011;120:56–62.
Mateescu B, Batista L, Cardon M, et al. miR‐141 and miR‐200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011;17:1627–35.
Tellez C, Juri D, Do K, et al. EMT and stem cell‐like properties associated with miR‐205 and miR‐200 epigenetic silencing are early manifestations during carcinogen‐induced transformation of human lung epithelial cells. Cancer Res, . 2011;71:3087–97.
Peng L, Wan-Jiang X, Ying F. Qin-Sheng Mao. MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1). Am J Transl Res. 2015;7(10):2053-9.
Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Molecular Cancer. 2009.
Fan F, Samuel S, Evans K, Lu J, Xia L, Zhou Y, et al. Overexpression of Snail induces epithelial– mesenchymal transition and a cancer stem cell– like phenotype in human colorectal cancer cells. Cancer Medicine. 2012.
Lin S, Lee Y, Yang S, Miller S, Chiou S, Hung M, et al. Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. Cancer Lett. 2013;328(8):226-34.
Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Molecular cancer. 2009;8(1):102.
Li P, Xue W-J, Feng Y, Mao Q-S. MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1). American journal of translational research. 2015;7(10):2053.
Lu Y, Lu J, Li X, Zhu H, Fan X, Zhu S, et al. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. BMC cancer. 2014;14(1):85.
Mirzaei S, Baghaei K, Parivar K, Hashemi M, Aghdaei HA. The expression level changes of microRNAs 200a/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition. European journal of pharmacology. 2019;857:172426.
- Abstract Viewed: 127 times
- PDF Downloaded: 95 times